Spend enough time watching patient questions, and a pattern emerges: it’s not just “does this work?” or “is this safe?”—it’s […]

If you want to understand drug shortages, don’t start with FDA dashboards. Start with patient questions. They don’t say “supply

Spend enough time watching patient questions, and a pattern emerges: people aren’t just asking what works—they’re asking what they can

A look at the $50B opportunity reshaping how pharma companies launch, monitor, and defend their brands in the age of

An investigative report on how large language models misrepresent prescription drugs, what that costs manufacturers, and why most brand teams

Physicians are increasingly asking AI chatbots how to dose drugs, manage contraindications, and choose between therapies. The AI answers. The

If you want to understand how patients actually think about switching between similar drugs, don’t look for clean “Drug A

Scroll through enough patient questions and a pattern emerges: people aren’t just taking drugs—they’re tuning them. Combining, stretching, substituting. Off-label

If you want to know when adherence breaks, don’t look at refill data. That’s the autopsy. The early signals show

The pharmaceutical industry has spent decades building brand reputations through clinical trials, physician detailing, and tightly controlled messaging. That infrastructure

Why Pharmaceutical Brands Must Shift from Social Listening to AI Monitoring — Before Regulators Do The clinical detail rep used

How pharmaceutical brands are losing control of patient conversations, clinical narratives, and competitive positioning inside the black box of generative